The IMpower-132 trial for non small cell lung cancer
29 Oct 2018
The IMpower-132 trial for non small cell lung cancer
Current clinical landscape for ALK non-small cell lung cancer patients
20 year followup on high-dose chemo with HSCT in high-risk breast cancer
The Circulating Cell-Free Genome Atlas Study
IMpassion 130 trial results: Immunotherapy for metastatic breast cancer
The TRIBE-2 study for colorectal cancer
Advances in metastatic non small cell lung cancer
Detecting copy number alterations using a pre-natal test
Comment on the JAVELIN study: RCC immunotherapy
Use of T-VEC in early metastatic melanoma
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC
PEACE: Collecting cancer tissue to solve the riddle of metastasis